|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.
The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.
|Rat F2 ORF mammalian expression plasmid, C-GFPSpark tag||RG80722-ACG|
|Rat F2 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||RG80722-ACR|
|Rat F2 ORF mammalian expression plasmid, C-Flag tag||RG80722-CF|
|Rat F2 ORF mammalian expression plasmid, C-His tag||RG80722-CH|
|Rat F2 ORF mammalian expression plasmid, C-Myc tag||RG80722-CM|
|Rat F2 ORF mammalian expression plasmid, C-HA tag||RG80722-CY|
|Rat F2 ORF mammalian expression plasmid, N-Flag tag||RG80722-NF|
|Rat F2 ORF mammalian expression plasmid, N-His tag||RG80722-NH|
|Rat F2 ORF mammalian expression plasmid, N-Myc tag||RG80722-NM|
|Rat F2 ORF mammalian expression plasmid, N-HA tag||RG80722-NY|
|Rat F2 Gene cDNA clone plasmid||RG80722-U|
|Rat F2 natural ORF mammalian expression plasmid||RG80722-UT|
|Learn more about expression Vectors|
Coagulation Factor II Protein (FII, F2 Protein or Prothrombin) is proteolytically cleaved to form thrombin in the first step of the coagulation cascade which ultimately results in the stemming of blood loss. Coagulation Factor II Protein (FII, F2 Protein) also plays a role in maintaining vascular integrity during development and postnatal life. Prothrombin / Coagulation Factor II is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin / Coagulation Factor II and factor Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin. Prothrombin / Coagulation Factor II is expressed by the liver and secreted in plasma. Defects in prothrombin / Coagulation Factor II are the cause of factor II deficiency (FA2D). It is very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Defects in Coagulation Factor II are also a cause of susceptibility to thrombosis. It is a multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation.